改善尿路感染抗生素选择的管理提示:INSPIRE随机临床试验
在59家美国社区医院开展整群随机试验,评估计算机化医嘱录入(CPOE)提示对非危重尿路感染成人经验性广谱抗生素使用的影响。与常规管理相比,CPOE提示组经验性广谱抗生素治疗天数降低17.4%(95%CI 11.2%-23.2%),率比0.83(95%CI 0.77-0.89,P<.001),ICU转入天数和住院时长无显著差异。
要点
- CPOE提示组经验性广谱抗生素治疗天数较常规管理组降低17.4%(95%CI 11.2%-23.2%)。
- 率比0.83(95%CI 0.77-0.89,P<.001),提示干预显著减少广谱抗生素使用。
- ICU转入平均天数(6.6 vs 7.0天)和住院时长(6.3 vs 6.5天)两组无显著差异。
核心结论
- 与常规管理相比,针对低多重耐药菌风险患者提供标准谱抗生素实时推荐的CPOE提示联合反馈与教育,显著减少非危重尿路感染住院成人的经验性广谱抗生素使用,且未改变住院时长或ICU转入天数。
研究设计与样本
- 整群随机试验,纳入59家美国社区医院,比较CPOE管理捆绑(教育、反馈及实时和基于风险的CPOE提示;29家医院)与常规管理(30家医院)对非危重成人(≥18岁)尿路感染住院患者住院前3天(经验期)抗生素选择的影响,基线期18个月(2017年4月1日至2018年9月30日),干预期15个月(2019年4月1日至2020年6月30日)。
- 共纳入127 403例成人患者(基线期71 991例,干预期55 412例),平均(SD)年龄69.4(17.9)岁,30.5%为男性,Elixhauser合并症指数中位数为4(IQR,2-5)。
主要发现
- 与常规管理相比,CPOE提示组经验性广谱抗生素治疗天数降低17.4%(95%CI,11.2%-23.2%)(率比0.83[95%CI,0.77-0.89];P<.001)。
- 常规管理组与干预组平均ICU转入天数分别为7.0天与6.6天,住院时长分别为6.5天与6.3天,均无显著差异。
关键数值与推荐
- CPOE提示推荐对估计绝对风险<10%的多重耐药菌尿路感染患者,在开具广谱抗生素医嘱时经验性使用标准谱抗生素,并联合反馈与教育。
- 主要结局为经验性(住院前3天)广谱抗生素治疗天数;次要结局包括经验性万古霉素和抗假单胞菌治疗天数;安全性结局包括ICU转入天数和住院时长。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Urinary tract infection (UTI) is the second most common infection leading to hospitalization and is often associated with gram-negative multidrug-resistant organisms (MDROs). Clinicians overuse extended-spectrum antibiotics although most patients are at low risk for MDRO infection. Safe strategies to limit overuse of empiric antibiotics are needed. OBJECTIVE: To evaluate whether computerized provider order entry (CPOE) prompts providing patient- and pathogen-specific MDRO risk estimates could reduce use of empiric extended-spectrum antibiotics for treatment of UTI. DESIGN, SETTING, AND PARTICIPANTS: Cluster-randomized trial in 59 US community hospitals comparing the effect of a CPOE stewardship bundle (education, feedback, and real-time and risk-based CPOE prompts; 29 hospitals) vs routine stewardship (n = 30 hospitals) on antibiotic selection during the first 3 hospital days (empiric period) in noncritically ill adults (≥18 years) hospitalized with UTI with an 18-month baseline (April 1, 2017-September 30, 2018) and 15-month intervention period (April 1, 2019-June 30, 2020). INTERVENTIONS: CPOE prompts recommending empiric standard-spectrum antibiotics in patients ordered to receive extended-spectrum antibiotics who have low estimated absolute risk (<10%) of MDRO UTI, coupled with feedback and education. MAIN OUTCOMES AND MEASURES: The primary outcome was empiric (first 3 days of hospitalization) extended-spectrum antibiotic days of therapy. Secondary outcomes included empiric vancomycin and antipseudomonal days of therapy. Safety outcomes included days to intensive care unit (ICU) transfer and hospital length of stay. Outcomes were assessed using generalized linear mixed-effect models to assess differences between the baseline and intervention periods. RESULTS: Among 127 403 adult patients (71 991 baseline and 55 412 intervention period) admitted with UTI in 59 hospitals, the mean (SD) age was 69.4 (17.9) years, 30.5% were male, and the median Elixhauser Comorbidity Index count was 4 (IQR, 2-5). Compared with routine stewardship, the group using CPOE prompts had a 17.4% (95% CI, 11.2%-23.2%) reduction in empiric extended-spectrum days of therapy (rate ratio, 0.83 [95% CI, 0.77-0.89]; P < .001). The safety outcomes of mean days to ICU transfer (6.6 vs 7.0 days) and hospital length of stay (6.3 vs 6.5 days) did not differ significantly between the routine and intervention groups, respectively. CONCLUSIONS AND RELEVANCE: Compared with routine stewardship, CPOE prompts providing real-time recommendations for standard-spectrum antibiotics for patients with low MDRO risk coupled with feedback and education significantly reduced empiric extended-spectrum antibiotic use among noncritically ill adults admitted with UTI without changing hospital length of stay or days to ICU transfers. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT03697096.
引用
- Gohil SK, Septimus E, Kleinman K, et al. Stewardship Prompts to Improve Antibiotic Selection for Urinary Tract Infection: The INSPIRE Randomized Clinical Trial. JAMA. 2024. PMID: 38639723. doi:10.1001/jama.2024.6259
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。